PSMAddition: a phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC

Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.